http://www.pharmajournalist.com/fda-grants-orphan-status-to-cellenkos-ck0804-in-myelofibrosis/ 2026-01-09T11:21:02+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/fda-grants-fast-track-to-alessas-localized-prostate-cancer-therapy/ 2026-01-09T11:22:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/synaffix-and-sidewinder-partner-to-develop-next-generation-bispecific-adcs/ 2026-01-09T11:23:57+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/lonza.jpg http://www.pharmajournalist.com/bd-invests-110-million-to-expand-u-s-prefillable-syringe-manufacturing/ 2026-01-14T14:19:04+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/Finance.jpg http://www.pharmajournalist.com/fda-approves-zycubo-as-first-treatment-for-rare-menkes-disease/ 2026-01-14T14:20:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/abbvie-to-acquire-wests-arizona-device-manufacturing-facility/ 2026-01-14T14:23:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/abbvie.jpg http://www.pharmajournalist.com/abbvie-licenses-remegens-rc148-in-major-oncology-partnership/ 2026-01-14T14:26:56+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/abbvie-logo.jpg http://www.pharmajournalist.com/abbvie-reaches-deal-with-trump-administration-on-drug-pricing/ 2026-01-14T14:28:08+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Abbvie.jpg http://www.pharmajournalist.com/fda-issues-complete-response-letter-for-ataras-ebvallo-therapy/ 2026-01-14T14:30:36+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/nvidia-and-lilly-launch-1-billion-ai-drug-discovery-lab/ 2026-01-14T14:32:30+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/Finance.jpg http://www.pharmajournalist.com/novartis-licenses-scineuros-brain-targeting-alzheimers-antibody-program/ 2026-01-14T14:34:08+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/illumina-launches-billion-cell-atlas-to-power-ai-drug-discovery/ 2026-01-14T14:49:36+00:00 https://pharmajournalist.com/wp-content/uploads/2026/01/AI-in-drug.png http://www.pharmajournalist.com/interax-alveus-partner-to-advance-next-generation-obesity-therapy/ 2026-01-16T11:24:47+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/solid-biosciences-advances-gene-therapy-for-friedreichs-ataxia/ 2026-01-16T11:26:39+00:00 https://pharmajournalist.com/wp-content/uploads/2023/01/solid-biosciences.jpg http://www.pharmajournalist.com/ema-fda-set-global-principles-for-ai-in-medicines/ 2026-01-16T11:28:51+00:00 https://pharmajournalist.com/wp-content/uploads/2026/01/AI-in-drug.png http://www.pharmajournalist.com/agenus-zydus-finalize-strategic-immunotherapy-collaboration/ 2026-01-16T11:30:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agenus.jpg http://www.pharmajournalist.com/astrazeneca-acquires-modella-ai-to-advance-oncology-innovation/ 2026-01-16T11:33:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/shionogi-expands-stake-in-viiv-healthcare-after-pfizer-exit/ 2026-01-22T13:51:43+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/bms-and-microsoft-partner-to-advance-ai-based-lung-cancer-detection/ 2026-01-22T13:53:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/bristol-myers-squibb.jpg http://www.pharmajournalist.com/novo-nordisk-and-aspect-deepen-cell-therapy-alliance-in-diabetes/ 2026-01-22T13:55:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/novo-nordisk-logo.jpg http://www.pharmajournalist.com/opna-bios-zavabresib-wins-fda-orphan-status-in-myelofibrosis/ 2026-01-22T13:56:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/iregenes-parkinsons-cell-therapy-secures-fda-rmat-designation/ 2026-01-22T13:58:37+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/astrazeneca-secures-full-global-rights-to-abelzetas-c-car031/ 2026-01-22T14:01:49+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/novartis-ianalumab-earns-fda-breakthrough-status-in-sjogrens-disease/ 2026-01-22T14:03:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/neok-bio-wins-fda-ind-clearance-for-bispecific-adc-neok001/ 2026-01-22T14:05:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/charles-river-and-gazi-university-partner-on-gene-therapy-development/ 2026-01-22T14:07:03+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Charles-River.jpeg http://www.pharmajournalist.com/wugens-sofi-cel-secures-fda-breakthrough-status-in-t-all-lbl/ 2026-01-22T14:08:26+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/insilico-and-hygtia-partner-to-advance-ai-discovered-nlrp3-inhibitor/ 2026-01-22T14:12:41+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/china-approves-enhertu-for-second-line-her2-positive-gastric-cancer/ 2026-01-23T11:11:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/Daiichi-Pharma.jpg http://www.pharmajournalist.com/janux-and-bristol-myers-squibb-forge-global-oncology-collaboration/ 2026-01-23T11:14:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/bristol-myers-squibb.jpg http://www.pharmajournalist.com/corxel-raises-287-million-to-advance-cardiometabolic-drug-pipeline/ 2026-01-28T09:41:29+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/Finance.jpg http://www.pharmajournalist.com/fda-reviews-weekly-subcutaneous-dosing-option-for-eisais-alzheimers-drug/ 2026-01-28T09:42:43+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/EISAI.jpg http://www.pharmajournalist.com/mirum-completes-bluejay-acquisition-expands-rare-liver-disease-pipeline/ 2026-01-28T09:43:53+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/insilico-and-qilu-forge-ai-driven-cardiometabolic-drug-partnership/ 2026-01-28T09:45:47+00:00 https://pharmajournalist.com/wp-content/uploads/2026/01/AI-in-drug.png http://www.pharmajournalist.com/simcere-boehringer-partner-on-bispecific-antibody-for-ibd-treatment/ 2026-01-28T09:47:45+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/Boehringer-Ingelheim.jpg http://www.pharmajournalist.com/wuxi-biologics-and-hanchorbio-partner-on-next-generation-fusion-therapies/ 2026-01-28T09:49:46+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/ema-panel-backs-rezurock-for-hard-to-treat-chronic-gvhd/ 2026-01-30T13:24:32+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/repertoire-lilly-team-up-on-tolerizing-autoimmune-therapies/ 2026-01-30T13:25:59+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/astrazeneca-pledges-15bn-to-expand-china-rd-manufacturing/ 2026-01-30T13:27:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/astrazeneca-cspc-partner-on-next-generation-obesity-therapies/ 2026-01-30T13:29:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astrazeneca.jpg http://www.pharmajournalist.com/sensorion-raises-e60m-to-advance-gene-therapies-for-hearing-loss/ 2026-01-30T13:31:22+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/Finance.jpg http://www.pharmajournalist.com/fda-grants-breakthrough-status-to-biogens-lupus-skin-therapy/ 2026-01-30T13:32:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/iqvia-boehringer-ingelheim-partner-on-global-commercial-data-transformation/ 2026-01-30T13:34:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/boehringer-ingelheim.jpg http://www.pharmajournalist.com/fda-grants-priority-review-to-otsukas-novel-adhd-drug/ 2026-01-30T13:36:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/otsuka-europe.jpg http://www.pharmajournalist.com/recordati-moderna-partner-on-mrna-therapy-for-rare-metabolic-disease/ 2026-01-30T13:38:24+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Moderna.jpg http://www.pharmajournalist.com/wuxi-biologics-sinorda-partner-on-bispecific-antibody-for-ibd/ 2026-01-30T13:40:22+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/fda-grants-breakthrough-status-to-immix-al-amyloidosis-therapy/ 2026-01-30T13:42:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/grunenthal-apotex-sign-deal-for-nebido-canada-rights/ 2026-02-06T13:25:09+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/eisai-henlius-partner-to-bring-serplulimab-to-japan/ 2026-02-06T13:26:38+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/EISAI.jpg http://www.pharmajournalist.com/everest-medicines-licenses-novel-kidney-disease-drug-mt1013/ 2026-02-06T13:28:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/primegen-us-plans-nasdaq-listing-via-1-5b-spac-deal/ 2026-02-06T13:31:17+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/Finance.jpg http://www.pharmajournalist.com/fda-grants-breakthrough-status-to-relay-breast-cancer-therapy/ 2026-02-06T13:33:30+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/cepi-samsung-biologics-partner-for-rapid-pandemic-vaccine-production/ 2026-02-06T13:36:20+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/genentech-licenses-sanegenebio-rnai-therapy-in-1-5b-deal/ 2026-02-06T13:37:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/Genentech-Image.jpg http://www.pharmajournalist.com/fda-issues-complete-response-letter-for-aquestive-allergy-film/ 2026-02-06T13:39:10+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/measuring-impact-in-medical-affairs-summit-redefining-how-medical-affairs-can-demonstrate-its-strategic-value/ 2026-02-11T09:11:11+00:00 https://pharmajournalist.com/wp-content/uploads/2025/11/Measuring-Impact-in-Medical-Affairs.png http://www.pharmajournalist.com/biocodex-thx-pharma-partner-on-rare-disease-therapies/ 2026-02-11T10:39:28+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/fda-rejects-regenxbio-gene-therapy-for-hunter-syndrome/ 2026-02-11T10:40:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/fda-grants-priority-review-to-takeda-narcolepsy-drug/ 2026-02-11T10:42:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/takeda-partners-with-iambic-to-accelerate-ai-drug-discovery/ 2026-02-11T10:44:37+00:00 https://pharmajournalist.com/wp-content/uploads/2026/01/AI-in-drug.png http://www.pharmajournalist.com/ampersand-acquires-purna-to-expand-global-pharma-services/ 2026-02-13T12:09:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/madrigal-expands-mash-pipeline-with-global-sirna-licensing-deal/ 2026-02-13T12:11:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/citius-expands-lymphir-access-across-europe-with-uniphar-deal/ 2026-02-13T12:12:57+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/Finance.jpg http://www.pharmajournalist.com/fda-clears-keytruda-combo-for-resistant-ovarian-cancer/ 2026-02-13T12:14:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/moderna-signs-mexico-pact-for-local-mrna-vaccine-production/ 2026-02-13T12:16:48+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Moderna.jpg http://www.pharmajournalist.com/fda-declines-review-of-moderna-mrna-flu-vaccine-filing/ 2026-02-13T12:17:57+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/europe-approves-uplizna-for-generalized-myasthenia-gravis/ 2026-02-13T12:19:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/amgen.jpg http://www.pharmajournalist.com/sanofi-replaces-ceo-paul-hudson-with-belen-garijo/ 2026-02-13T12:21:16+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/insilico-cms-partner-on-ai-drug-discovery-programs/ 2026-02-13T12:22:40+00:00 https://pharmajournalist.com/wp-content/uploads/2026/01/AI-in-drug.png http://www.pharmajournalist.com/arkbio-wins-u-s-clearance-for-ipf-drug-trial/ 2026-02-13T12:24:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/kincell-bio-partners-regcell-to-advance-treg-therapy-trials/ 2026-02-13T12:28:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.png http://www.pharmajournalist.com/the-5th-lnp-summit-featuring-end-to-end-tracks-pre-conference-workshops-and-team-discounts/ 2026-02-13T12:34:19+00:00 https://pharmajournalist.com/wp-content/uploads/2025/11/LNP-US-Pharma-J.png http://www.pharmajournalist.com/the-toxicology-meeting-thats-different-made-for-biotech-and-pharma-leaders/ 2026-02-17T12:19:40+00:00 https://pharmajournalist.com/wp-content/uploads/2026/02/IPT-Banner-Pharma-Journalist.png http://www.pharmajournalist.com/teijin-aska-partner-on-gynecology-drug-discovery/ 2026-02-17T12:29:01+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/ptc-withdraws-translarna-fda-application-after-feedback/ 2026-02-17T12:30:55+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/PTC-Therapeutics.jpg http://www.pharmajournalist.com/fda-rejects-bitopertin-accelerated-approval-for-rare-disorder/ 2026-02-17T12:32:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/immunic-raises-400m-to-advance-ms-drug-plans/ 2026-02-17T12:33:59+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/Finance.jpg http://www.pharmajournalist.com/boehringer-ingelheim-niper-raebareli-sign-research-mou/ 2026-02-20T11:05:21+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/Boehringer-Ingelheim.jpg http://www.pharmajournalist.com/johnson-johnson-invests-1-billion-in-pennsylvania/ 2026-02-20T11:07:00+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Johnson-Johnson-Logo.png http://www.pharmajournalist.com/johnson-johnson-reports-promising-origami-4-trial-results/ 2026-02-20T11:10:50+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Johnson-Johnson-Logo.png http://www.pharmajournalist.com/novartis-remibrutinib-shows-phase-iii-success-in-cindu/ 2026-02-20T11:12:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/merck-mayo-clinic-partner-on-ai-drug-development/ 2026-02-20T11:13:30+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/vivamed-syngene-partner-to-accelerate-ai-drug-validation/ 2026-02-20T11:16:24+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/catalent-s-biomedics-partner-on-parkinsons-cell-therapy/ 2026-02-20T11:18:24+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/unnatural-products-novartis-partner-on-macrocyclic-therapies/ 2026-02-20T11:19:46+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/scribe-lilly-advance-crispr-therapies-with-milestone/ 2026-02-20T11:21:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/fda-issues-draft-guidance-for-individualized-gene-therapies/ 2026-02-24T14:08:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/fda-approves-abbvies-oral-cll-combination-regimen/ 2026-02-24T14:11:03+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Abbvie.jpg http://www.pharmajournalist.com/gilead-to-acquire-arcellx-in-7-8-billion-deal/ 2026-02-24T14:13:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg http://www.pharmajournalist.com/eu-invests-e225m-in-next-generation-flu-vaccines/ 2026-02-24T14:15:08+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/Finance.jpg http://www.pharmajournalist.com/fda-approves-calquence-venetoclax-fixed-duration-regimen/ 2026-02-24T14:17:01+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astrazeneca.jpg http://www.pharmajournalist.com/abbvie-invests-380m-in-north-chicago-manufacturing/ 2026-02-24T14:18:21+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Abbvie.jpg http://www.pharmajournalist.com/industry-innovators-set-to-gather-in-philadelphia-for-smartlab-exchange-usa-2026-will-you-be-there/ 2026-02-27T12:04:57+00:00 https://pharmajournalist.com/wp-content/uploads/2026/02/SmartLab-Exchange-USA-Press-Release-Photo-3.jpg https://pharmajournalist.com/wp-content/uploads/2026/02/SmartLab-Exchange-USA-Press-Release-Photo-3.jpg http://www.pharmajournalist.com/asahi-kasei-expands-global-pharma-reach-with-e780-million-buy-of-aicuris/ 2026-02-27T12:16:09+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/Finance.jpg http://www.pharmajournalist.com/iqvia-to-acquire-discovery-assets-from-charles-river/ 2026-02-27T12:17:43+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Charles-River.jpeg http://www.pharmajournalist.com/novo-nordisk-partners-vivtex-on-oral-biologics/ 2026-02-27T12:19:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/novo-nordisk-logo.jpg http://www.pharmajournalist.com/gsk-to-acquire-35pharma-for-pulmonary-hypertension-drug/ 2026-02-27T12:20:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/viiv-reports-strong-12-month-data-for-hiv-antibody-regimen/ 2026-02-27T12:22:35+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/ViiV-Healthcare.png http://www.pharmajournalist.com/china-grants-priority-review-to-gsks-linerixibat/ 2026-02-27T12:23:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/gsk.jpg http://www.pharmajournalist.com/japan-reviews-gsks-bepirovirsen-for-hepatitis-b/ 2026-02-27T12:25:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/slate-medicines-launches-with-130m-series-a/ 2026-02-27T12:27:33+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/Finance.jpg http://www.pharmajournalist.com/quotient-sciences-extends-ipsen-fop-supply-deal/ 2026-02-27T12:30:43+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/Finance.jpg http://www.pharmajournalist.com/northx-and-demeetra-unite-to-accelerate-biologics-development/ 2026-02-27T12:32:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/fda-grants-fast-track-status-to-affinias-aftx-201-gene-therapy/ 2026-03-05T16:49:38+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/japan-grants-orphan-drug-status-to-rilzabrutinib-for-igg4-disease/ 2026-03-05T16:51:47+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/esperion-to-acquire-corstasis-expanding-heart-failure-treatment-portfolio/ 2026-03-05T16:54:56+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/cordenpharma-leases-new-lab-facility-at-boulders-flatiron-park/ 2026-03-05T16:57:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/cordenpharma1.jpg http://www.pharmajournalist.com/5th-adc-analytical-development-summit-unveils-2026-agenda-to-tackle-emerging-complexity-in-next-generation-adcs/ 2026-03-05T17:04:24+00:00 https://pharmajournalist.com/wp-content/uploads/2026/01/63025-Pharma-Journalist.jpg http://www.pharmajournalist.com/tenaya-and-alnylam-partner-to-discover-new-genetic-targets-for-heart-disease/ 2026-03-06T13:10:26+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/akeso-and-inovio-partner-on-novel-glioblastoma-combination-trial/ 2026-03-06T13:12:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.png http://www.pharmajournalist.com/antengene-licenses-atg-201-to-ucb-in-1-1b-deal/ 2026-03-06T13:14:22+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/ucb-pharma.jpg http://www.pharmajournalist.com/sinopia-and-ono-partner-to-discover-targets-for-rare-metabolic-diseases/ 2026-03-06T13:15:56+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/novo-nordisk-invests-e432m-to-expand-irish-glp-1-manufacturing/ 2026-03-06T13:19:01+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/novo-nordisk-logo.jpg http://www.pharmajournalist.com/liberate-bio-secures-car-m-patents-to-advance-in-vivo-cell-therapy/ 2026-03-06T13:21:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.png http://www.pharmajournalist.com/fda-approves-first-therapy-for-rare-cerebral-folate-deficiency/ 2026-03-11T10:43:10+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/novo-nordisk-partners-with-hims-hers-to-expand-semaglutide-access/ 2026-03-11T10:44:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/novo-nordisk-logo.jpg http://www.pharmajournalist.com/newcelx-eledon-partner-on-stem-cell-therapy-for-type-1-diabetes/ 2026-03-11T10:46:31+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/gsk-licenses-liver-disease-drug-linerixibat-to-alfasigma/ 2026-03-11T10:48:25+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/fda-proposes-new-steps-to-streamline-biosimilar-drug-development/ 2026-03-11T10:50:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/csl-seqirus-partners-with-paho-to-expand-flu-vaccines-in-latin-america/ 2026-03-11T10:52:08+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/exclusive-opportunity-partner-with-the-leaders-defining-the-future-of-the-digital-lab/ 2026-03-12T13:35:46+00:00 https://pharmajournalist.com/wp-content/uploads/2026/03/SLABS-USA-2026-Brands-Attending.jpg https://pharmajournalist.com/wp-content/uploads/2026/03/Investment-Priorities.jpg https://pharmajournalist.com/wp-content/uploads/2026/03/SLABS-USA-2026-Brands-Attending.jpg http://www.pharmajournalist.com/lilly-warns-of-safety-risks-in-compounded-tirzepatide-mixed-with-b12/ 2026-03-12T13:44:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/bavarian-nordic-expands-serum-institute-partnership-for-chikungunya-vaccine-production/ 2026-03-12T13:45:35+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/psiquantum-partners-with-japans-national-cancer-center-on-quantum-oncology-research/ 2026-03-13T13:30:30+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/vima-therapeutics-advances-dystonia-drug-into-phase-2-trials/ 2026-03-13T13:32:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/02/abzena-clinical.jpg http://www.pharmajournalist.com/idorsia-partners-with-pharmalink-to-expand-quviviq-across-gulf-states/ 2026-03-13T13:34:27+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/gsk-licenses-linerixibat-to-alfasigma-for-rare-liver-disease/ 2026-03-13T13:38:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/fda-approves-tecnis-puresee-lens-for-cataract-surgery/ 2026-03-13T13:39:42+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Johnson-Johnson-Logo.png http://www.pharmajournalist.com/gelmedix-catalent-partner-to-advance-stem-cell-vision-therapies/ 2026-03-13T13:41:14+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/digital-transformation-and-ai-powered-discovery-in-modern-laboratories/ 2026-03-18T13:19:29+00:00 https://pharmajournalist.com/wp-content/uploads/2026/02/SmartLab-Exchange-USA-Press-Release-Photo-3.jpg https://pharmajournalist.com/wp-content/uploads/2026/02/SmartLab-Exchange-USA-Press-Release-Photo-3.jpg http://www.pharmajournalist.com/how-smartlab-exchange-usa-helped-uncountable-accelerate-high-value-rd-partnerships/ 2026-03-18T13:22:41+00:00 https://pharmajournalist.com/wp-content/uploads/2026/03/54361494817_0b00dc49f8_o.jpg https://pharmajournalist.com/wp-content/uploads/2026/03/54361494817_0b00dc49f8_o.jpg http://www.pharmajournalist.com/fda-rejects-reproxalap-nda-over-efficacy-concerns/ 2026-03-18T13:25:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/fda-reviews-ilumya-for-psoriatic-arthritis-treatment/ 2026-03-18T13:27:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/SunPharma.jpg http://www.pharmajournalist.com/sentynl-licenses-progerinin-to-expand-progeria-treatment-pipeline/ 2026-03-18T13:28:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/r1-therapeutics-launches-with-77-5m-to-advance-kidney-drug/ 2026-03-18T13:30:01+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/Finance.jpg http://www.pharmajournalist.com/fda-expands-gsk-rsv-vaccine-to-younger-at-risk-adults/ 2026-03-18T13:31:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/fda-approves-cosentyx-for-pediatric-hidradenitis-suppurativa/ 2026-03-18T13:32:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/terumo-bct-taiwan-bio-partner-on-treg-manufacturing/ 2026-03-18T13:34:32+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/voro-daiichi-sankyo-partner-on-tumor-activated-adcs/ 2026-03-18T13:36:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/Daiichi-Pharma.jpg http://www.pharmajournalist.com/roche-expands-ai-infrastructure-with-massive-gpu-investment/ 2026-03-18T13:37:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/vir-biotechnology-and-astellas-announce-1-71b-partnership-accelerating-innovation-in-psma-targeting-tces/ 2026-03-19T12:05:50+00:00 https://pharmajournalist.com/wp-content/uploads/2026/03/69173-Pharma-Journalist.jpg http://www.pharmajournalist.com/novartis-targets-breast-cancer-with-novel-pi3k%ce%b1-inhibitor-deal/ 2026-03-20T11:21:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/uk-streamlines-drug-approvals-to-accelerate-patient-access/ 2026-03-20T11:23:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/drug.jpg http://www.pharmajournalist.com/excalipoint-raises-68-7m-to-advance-t-cell-therapies/ 2026-03-20T11:25:45+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/Finance.jpg http://www.pharmajournalist.com/fda-approves-first-oral-il-23-blocker-for-psoriasis/ 2026-03-20T11:27:10+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Johnson-Johnson-Logo.png http://www.pharmajournalist.com/earendil-labs-partners-wuxi-biologics-on-antibody-pipeline/ 2026-03-20T11:28:44+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/lgm-pharma-expands-u-s-manufacturing-with-15m-investment/ 2026-03-20T11:30:59+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/Finance.jpg http://www.pharmajournalist.com/akeso-advances-first-trispecific-antibody-into-clinical-trials/ 2026-03-20T11:32:51+00:00 https://pharmajournalist.com/wp-content/uploads/2017/02/abzena-clinical.jpg http://www.pharmajournalist.com/ucb-selects-georgia-for-major-u-s-biologics-manufacturing-hub/ 2026-03-26T11:56:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/ucb-pharma.jpg http://www.pharmajournalist.com/ucb-wins-ema-support-for-zilucoplan-pre-filled-pen/ 2026-03-26T11:57:26+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/ucb-pharma.jpg http://www.pharmajournalist.com/merck-to-acquire-terns-in-6-7-billion-deal/ 2026-03-26T11:59:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/viz-ai-alnylam-partner-to-improve-amyloidosis-diagnosis/ 2026-03-26T12:01:33+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/merck-quotient-partner-to-discover-new-ibd-drug-targets/ 2026-03-26T12:03:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.png http://www.pharmajournalist.com/gilead-to-acquire-ouro-medicines-to-expand-autoimmune-portfolio/ 2026-03-26T12:05:25+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg http://www.pharmajournalist.com/cognito-ochsner-launch-brain-health-collaboratory-initiative/ 2026-03-26T12:07:15+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/tempus-daiichi-sankyo-partner-to-advance-ai-driven-adc-development/ 2026-03-26T12:08:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/Daiichi-Pharma.jpg http://www.pharmajournalist.com/japan-approves-dupixent-for-bullous-pemphigoid-treatment/ 2026-03-26T12:10:22+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/sanofi-licenses-kalis-tri-specific-antibody-in-1b-deal/ 2026-03-26T12:13:33+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/fda-approves-lifyorli-for-platinum-resistant-ovarian-cancer/ 2026-03-26T12:15:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/zealand-pharma-expands-with-new-cambridge-research-hub/ 2026-03-26T12:19:47+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/zealand-logo.jpg http://www.pharmajournalist.com/in-vivo-cell-engineering-reaches-an-inflection-point-as-the-5th-in-vivo-cell-engineering-gene-editing-summit-returns-to-boston/ 2026-04-01T13:37:48+00:00 https://pharmajournalist.com/wp-content/uploads/2026/03/69781-Pharma-Journalist-Event-Listing-Banner.png http://www.pharmajournalist.com/fda-approves-higher-dose-spinraza-regimen-for-sma-patients/ 2026-04-01T13:40:17+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/biogen-to-acquire-apellis-in-5-6-billion-deal/ 2026-04-01T13:41:35+00:00 https://pharmajournalist.com/wp-content/uploads/2020/11/Biogen.jpg http://www.pharmajournalist.com/symeres-ambagon-partner-on-novel-cancer-drug-approach/ 2026-04-01T13:43:05+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/teva-advances-biosimilars-with-fda-approval-and-filings/ 2026-04-01T13:44:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/TEVA-Pharma.jpg http://www.pharmajournalist.com/lilly-to-acquire-centessa-in-6-3-billion-deal/ 2026-04-01T13:46:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/otsuka-to-acquire-transcend-in-1-2-billion-deal/ 2026-04-01T13:49:45+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/otsuka-europe.jpg http://www.pharmajournalist.com/sidewinder-therapeutics-secures-137m-to-advance-cancer-therapies/ 2026-04-09T08:25:04+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/Finance.jpg http://www.pharmajournalist.com/halozyme-vertex-partner-to-advance-drug-delivery-technology/ 2026-04-09T08:27:20+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/gilead-to-acquire-tubulis-expanding-adc-cancer-pipeline/ 2026-04-09T08:28:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg http://www.pharmajournalist.com/apnimed-secures-150m-to-advance-sleep-apnea-drug-launch/ 2026-04-09T08:30:15+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/Finance.jpg http://www.pharmajournalist.com/neurocrine-to-acquire-soleno-in-2-9-billion-deal/ 2026-04-09T08:31:52+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Neurocrine-Biosciences.jpg http://www.pharmajournalist.com/roosterbio-partners-minebio-to-expand-china-cell-therapy-market/ 2026-04-09T08:33:26+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/the-toxicology-workshop-day-industry-leaders-are-prioritizing-ahead-of-investigative-preclinical-toxicology-summit-2026/ 2026-04-09T08:36:49+00:00 https://pharmajournalist.com/wp-content/uploads/2026/02/SEO-social-image-70764.png http://www.pharmajournalist.com/targeted-lnp-delivery-beyond-the-liver-the-challenges-the-solution/ 2026-04-09T08:41:53+00:00 https://pharmajournalist.com/wp-content/uploads/2026/02/Extrahepatic-LNP-x-Pharma-Journalist.gif http://www.pharmajournalist.com/turning-biophysical-data-into-confident-drug-discovery-decisions/ 2026-04-09T08:45:33+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.png http://www.pharmajournalist.com/c4-therapeutics-and-roche-expand-cancer-research-collaboration/ 2026-04-10T10:00:26+00:00 https://pharmajournalist.com/wp-content/uploads/2021/08/C4-Therapeutics-Logo.jpg http://www.pharmajournalist.com/shionogi-wins-u-s-contract-to-advance-fetroja-antibiotic/ 2026-04-10T10:03:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/shionogi-logo.jpg http://www.pharmajournalist.com/jeito-raises-1-2-billion-fund-for-biopharma-investments/ 2026-04-10T10:06:50+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/Finance.jpg http://www.pharmajournalist.com/sidewinder-secures-137-million-for-next-gen-cancer-therapies/ 2026-04-10T10:08:37+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/Finance.jpg http://www.pharmajournalist.com/fda-reviews-telix-brain-cancer-imaging-drug-application/ 2026-04-10T10:10:15+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/Telix-Pharmaceuticals-Logo.jpg http://www.pharmajournalist.com/nxera-hits-milestone-in-lilly-diabetes-drug-partnership/ 2026-04-10T10:12:07+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/ac-immune-lilly-expand-alzheimers-drug-collaboration/ 2026-04-10T10:13:39+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/alloy-biogen-partner-on-next-gen-antisense-therapies/ 2026-04-10T10:15:04+00:00 https://pharmajournalist.com/wp-content/uploads/2021/05/Alloy-Therapeutics.png http://www.pharmajournalist.com/akari-partners-with-wuxi-xdc-on-novel-cancer-therapy/ 2026-04-10T10:16:47+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/4th-adc-linker-conjugation-summit-announces-2026-agenda-bringing-specialist-chemists-together-in-boston-this-july/ 2026-04-13T13:59:33+00:00 https://pharmajournalist.com/wp-content/uploads/2026/03/4th-ADC-Linker-Conjugation-Summit.jpg http://www.pharmajournalist.com/novo-nordisk-partners-with-openai-to-accelerate-drug-discovery/ 2026-04-14T15:54:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/novo-nordisk-logo.jpg http://www.pharmajournalist.com/fda-grants-priority-review-to-lung-cancer-drug-candidate/ 2026-04-14T15:57:55+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/Daiichi-Pharma.jpg http://www.pharmajournalist.com/abbvie-highlights-promising-ovarian-cancer-trial-results-at-sgo-2026/ 2026-04-14T15:59:40+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Abbvie.jpg http://www.pharmajournalist.com/telix-and-regeneron-partner-on-next-generation-cancer-therapies/ 2026-04-14T16:00:56+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/Telix-Pharmaceuticals-Logo.jpg http://www.pharmajournalist.com/fda-rejects-replimune-melanoma-therapy-citing-data-concerns/ 2026-04-14T16:02:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/iq-mps-leaders-to-share-industry-progress-on-advancing-in-vitro-nams-toward-regulatory-acceptance-at-the-investigative-preclinical-toxicology-summit/ 2026-04-14T16:05:32+00:00 https://pharmajournalist.com/wp-content/uploads/2026/02/SEO-social-image-70764.png http://www.pharmajournalist.com/aligos-licenses-hbv-drug-candidate-to-amoytop-in-china/ 2026-04-17T09:57:30+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/terremoto-raises-108m-to-advance-targeted-cancer-therapies/ 2026-04-17T10:00:39+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/Finance.jpg http://www.pharmajournalist.com/nucleai-and-sirona-dx-partner-on-spatial-proteomics/ 2026-04-17T10:01:54+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/boehringer-zai-lab-test-dual-dll3-cancer-therapy/ 2026-04-17T10:03:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/Boehringer-Ingelheim.jpg http://www.pharmajournalist.com/interna-daiichi-sankyo-partner-to-advance-drug-delivery-innovation/ 2026-04-17T10:28:10+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/Daiichi-Pharma.jpg http://www.pharmajournalist.com/piramal-ajinomoto-partner-to-advance-adc-manufacturing-capabilities/ 2026-04-17T10:30:36+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/sana-mayo-clinic-partner-on-diabetes-cell-therapy-development/ 2026-04-17T10:32:30+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/lilly-to-acquire-crossbridge-bio-in-300m-deal/ 2026-04-17T10:34:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/fda-expands-tzield-use-to-younger-children-with-type-1-diabetes/ 2026-04-23T10:47:59+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/fda-approves-mercks-new-two-drug-hiv-treatment-option/ 2026-04-23T10:50:26+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/bioaegis-and-prenosis-partner-to-advance-precision-ards-therapy/ 2026-04-23T10:51:41+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/biocon-wins-canada-approval-for-two-denosumab-biosimilars/ 2026-04-23T10:53:01+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/biocon.jpg http://www.pharmajournalist.com/abbvie-to-invest-1-4-billion-in-north-carolina-campus/ 2026-04-23T10:54:30+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/abbvie-logo.jpg http://www.pharmajournalist.com/msd-google-cloud-forge-1b-ai-partnership/ 2026-04-23T10:55:46+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/lilly-to-acquire-kelonia-in-7-billion-gene-therapy-deal/ 2026-04-23T10:59:22+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/fda-priority-review-for-padcev-combo-in-bladder-cancer/ 2026-04-23T11:01:08+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/boehringer-expands-ai-footprint-with-london-innovation-hub/ 2026-04-23T11:02:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/Boehringer-Ingelheim.jpg http://www.pharmajournalist.com/ucb-to-acquire-neurona-to-boost-epilepsy-pipeline/ 2026-04-23T11:04:33+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/ucb-pharma.jpg http://www.pharmajournalist.com/regeneron-goes-all-in-on-radiopharma-with-2-1b-telix-deal-as-industry-leaders-convene-at-trp-summit/ 2026-04-23T15:37:26+00:00 https://pharmajournalist.com/wp-content/uploads/2026/04/Screenshot-2026-03-06-165414.png http://www.pharmajournalist.com/cipla-wins-us-approval-for-generic-ventolin-inhaler/ 2026-04-24T08:23:01+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Cipla-Logo.png http://www.pharmajournalist.com/leinco-cellcarta-partner-to-advance-proteomics-in-oncology/ 2026-04-24T08:24:36+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/biogen-secures-global-rights-to-felzartamab-in-china-deal/ 2026-04-24T08:25:58+00:00 https://pharmajournalist.com/wp-content/uploads/2020/11/Biogen.jpg http://www.pharmajournalist.com/eu-approves-mercks-enflonsia-to-prevent-infant-rsv/ 2026-04-24T08:26:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/saphnelo-pen-approval-expands-lupus-treatment-access/ 2026-04-29T09:58:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astrazeneca.jpg http://www.pharmajournalist.com/lilly-to-acquire-ajax-in-2-3-billion-deal/ 2026-04-29T09:59:36+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/eu-approves-rhapsido-for-chronic-hives-treatment/ 2026-04-29T10:00:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/sun-pharma-to-acquire-organon-in-11-75-billion-deal/ 2026-04-29T10:02:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/SunPharma.jpg http://www.pharmajournalist.com/biomarin-completes-4-8-billion-amicus-acquisition/ 2026-04-29T10:04:11+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/Finance.jpg http://www.pharmajournalist.com/gilead-completes-7-8-billion-arcellx-acquisition-deal/ 2026-04-29T10:05:49+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg